Selected research
Industry Growth & Trends
Global Bromhexine Industry Growth and Trends Forecast to 2032
Market perspective
The global Bromhexine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Bromhexine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Bromhexine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bromhexine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bromhexine include Abbott, Takeda, Wanbangde Pharmaceutical Group, Teva, Shijiazhuang No.4 Pharmaceutical, Shanghai Xudong Haipu Pharmaceutical, Shanghai Sine Tianping Pharmaceutical, Shanxi Powerdone Pharmaceutical and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Bromhexine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Bromhexine market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bromhexine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bromhexine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Bromhexine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Bromhexine Market by Company
Abbott
Takeda
Wanbangde Pharmaceutical Group
Teva
Shijiazhuang No.4 Pharmaceutical
Shanghai Xudong Haipu Pharmaceutical
Shanghai Sine Tianping Pharmaceutical
Shanxi Powerdone Pharmaceutical
Sandoz
Shanxi Powerdone Pharmaceutical
Novartis
Mylan
Jincheng Haisi Pharmaceutical
GSK
Sigma-Aldrich
Sanyo Chemical Laboratroy
Sanofi Aventis
Mayne Pharma
Ma'AnShan BBCA Pharmaceutical
LGM Pharma
Boehringer Ingelheim
Bromhexine Segment by Type
Oral
Injection
Bromhexine Segment by Application
Chronic Bronchitis
Asthma
Others
Bromhexine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bromhexine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bromhexine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bromhexine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bromhexine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Bromhexine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Chronic Bronchitis
- Asthma
- Others
Companies covered
- Abbott
- Takeda
- Wanbangde Pharmaceutical Group
- Teva
- Shijiazhuang No.4 Pharmaceutical
- Shanghai Xudong Haipu Pharmaceutical
- Shanghai Sine Tianping Pharmaceutical
- Shanxi Powerdone Pharmaceutical
- Sandoz
- Shanxi Powerdone Pharmaceutical
- Novartis
- Mylan
- Jincheng Haisi Pharmaceutical
- GSK
- Sigma-Aldrich
- Sanyo Chemical Laboratroy
- Sanofi Aventis
- Mayne Pharma
- Ma'AnShan BBCA Pharmaceutical
- LGM Pharma
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Bromhexine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Bromhexine Sales Estimates and Forecasts (2021-2032)
- 1.3 Bromhexine Market by Type
- 1.3.1 Oral
- 1.3.2 Injection
- 1.4 Global Bromhexine Market Size by Type
- 1.4.1 Global Bromhexine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Bromhexine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Bromhexine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Bromhexine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Bromhexine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Bromhexine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Bromhexine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Bromhexine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Bromhexine Industry Trends
- 2.2 Bromhexine Industry Drivers
- 2.3 Bromhexine Industry Opportunities and Challenges
- 2.4 Bromhexine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Bromhexine Revenue (2021-2026)
- 3.2 Global Top Players by Bromhexine Sales (2021-2026)
- 3.3 Global Top Players by Bromhexine Price (2021-2026)
- 3.4 Global Bromhexine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bromhexine Major Company Production Sites & Headquarters
- 3.6 Global Bromhexine Company, Product Type & Application
- 3.7 Global Bromhexine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bromhexine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bromhexine Players Market Share by Revenue in 2025
- 3.8.3 2025 Bromhexine Tier 1, Tier 2, and Tier 3
4 Bromhexine Regional Status and Outlook
- 4.1 Global Bromhexine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Bromhexine Historic Market Size by Region
- 4.2.1 Global Bromhexine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Bromhexine Sales in Value by Region (2021-2026)
- 4.2.3 Global Bromhexine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Bromhexine Forecasted Market Size by Region
- 4.3.1 Global Bromhexine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Bromhexine Sales in Value by Region (2027-2032)
- 4.3.3 Global Bromhexine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bromhexine by Application
- 5.1 Bromhexine Market by Application
- 5.1.1 Chronic Bronchitis
- 5.1.2 Asthma
- 5.1.3 Others
- 5.2 Global Bromhexine Market Size by Application
- 5.2.1 Global Bromhexine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Bromhexine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Bromhexine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Bromhexine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Bromhexine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Bromhexine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Bromhexine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Bromhexine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Abbott Bromhexine Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Takeda
- 6.2.1 Takeda Company Information
- 6.2.2 Takeda Business Overview
- 6.2.3 Takeda Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Takeda Bromhexine Product Portfolio
- 6.2.5 Takeda Recent Developments
- 6.3 Wanbangde Pharmaceutical Group
- 6.3.1 Wanbangde Pharmaceutical Group Company Information
- 6.3.2 Wanbangde Pharmaceutical Group Business Overview
- 6.3.3 Wanbangde Pharmaceutical Group Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Wanbangde Pharmaceutical Group Bromhexine Product Portfolio
- 6.3.5 Wanbangde Pharmaceutical Group Recent Developments
- 6.4 Teva
- 6.4.1 Teva Company Information
- 6.4.2 Teva Business Overview
- 6.4.3 Teva Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Teva Bromhexine Product Portfolio
- 6.4.5 Teva Recent Developments
- 6.5 Shijiazhuang No.4 Pharmaceutical
- 6.5.1 Shijiazhuang No.4 Pharmaceutical Company Information
- 6.5.2 Shijiazhuang No.4 Pharmaceutical Business Overview
- 6.5.3 Shijiazhuang No.4 Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Shijiazhuang No.4 Pharmaceutical Bromhexine Product Portfolio
- 6.5.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
- 6.6 Shanghai Xudong Haipu Pharmaceutical
- 6.6.1 Shanghai Xudong Haipu Pharmaceutical Company Information
- 6.6.2 Shanghai Xudong Haipu Pharmaceutical Business Overview
- 6.6.3 Shanghai Xudong Haipu Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Shanghai Xudong Haipu Pharmaceutical Bromhexine Product Portfolio
- 6.6.5 Shanghai Xudong Haipu Pharmaceutical Recent Developments
- 6.7 Shanghai Sine Tianping Pharmaceutical
- 6.7.1 Shanghai Sine Tianping Pharmaceutical Company Information
- 6.7.2 Shanghai Sine Tianping Pharmaceutical Business Overview
- 6.7.3 Shanghai Sine Tianping Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Shanghai Sine Tianping Pharmaceutical Bromhexine Product Portfolio
- 6.7.5 Shanghai Sine Tianping Pharmaceutical Recent Developments
- 6.8 Shanxi Powerdone Pharmaceutical
- 6.8.1 Shanxi Powerdone Pharmaceutical Company Information
- 6.8.2 Shanxi Powerdone Pharmaceutical Business Overview
- 6.8.3 Shanxi Powerdone Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Shanxi Powerdone Pharmaceutical Bromhexine Product Portfolio
- 6.8.5 Shanxi Powerdone Pharmaceutical Recent Developments
- 6.9 Sandoz
- 6.9.1 Sandoz Company Information
- 6.9.2 Sandoz Business Overview
- 6.9.3 Sandoz Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Sandoz Bromhexine Product Portfolio
- 6.9.5 Sandoz Recent Developments
- 6.10 Shanxi Powerdone Pharmaceutical
- 6.10.1 Shanxi Powerdone Pharmaceutical Company Information
- 6.10.2 Shanxi Powerdone Pharmaceutical Business Overview
- 6.10.3 Shanxi Powerdone Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Shanxi Powerdone Pharmaceutical Bromhexine Product Portfolio
- 6.10.5 Shanxi Powerdone Pharmaceutical Recent Developments
- 6.11 Novartis
- 6.11.1 Novartis Company Information
- 6.11.2 Novartis Business Overview
- 6.11.3 Novartis Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Novartis Bromhexine Product Portfolio
- 6.11.5 Novartis Recent Developments
- 6.12 Mylan
- 6.12.1 Mylan Company Information
- 6.12.2 Mylan Business Overview
- 6.12.3 Mylan Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Mylan Bromhexine Product Portfolio
- 6.12.5 Mylan Recent Developments
- 6.13 Jincheng Haisi Pharmaceutical
- 6.13.1 Jincheng Haisi Pharmaceutical Company Information
- 6.13.2 Jincheng Haisi Pharmaceutical Business Overview
- 6.13.3 Jincheng Haisi Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Jincheng Haisi Pharmaceutical Bromhexine Product Portfolio
- 6.13.5 Jincheng Haisi Pharmaceutical Recent Developments
- 6.14 GSK
- 6.14.1 GSK Company Information
- 6.14.2 GSK Business Overview
- 6.14.3 GSK Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 GSK Bromhexine Product Portfolio
- 6.14.5 GSK Recent Developments
- 6.15 Sigma-Aldrich
- 6.15.1 Sigma-Aldrich Company Information
- 6.15.2 Sigma-Aldrich Business Overview
- 6.15.3 Sigma-Aldrich Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Sigma-Aldrich Bromhexine Product Portfolio
- 6.15.5 Sigma-Aldrich Recent Developments
- 6.16 Sanyo Chemical Laboratroy
- 6.16.1 Sanyo Chemical Laboratroy Company Information
- 6.16.2 Sanyo Chemical Laboratroy Business Overview
- 6.16.3 Sanyo Chemical Laboratroy Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Sanyo Chemical Laboratroy Bromhexine Product Portfolio
- 6.16.5 Sanyo Chemical Laboratroy Recent Developments
- 6.17 Sanofi Aventis
- 6.17.1 Sanofi Aventis Company Information
- 6.17.2 Sanofi Aventis Business Overview
- 6.17.3 Sanofi Aventis Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Sanofi Aventis Bromhexine Product Portfolio
- 6.17.5 Sanofi Aventis Recent Developments
- 6.18 Mayne Pharma
- 6.18.1 Mayne Pharma Company Information
- 6.18.2 Mayne Pharma Business Overview
- 6.18.3 Mayne Pharma Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Mayne Pharma Bromhexine Product Portfolio
- 6.18.5 Mayne Pharma Recent Developments
- 6.19 Ma'AnShan BBCA Pharmaceutical
- 6.19.1 Ma'AnShan BBCA Pharmaceutical Company Information
- 6.19.2 Ma'AnShan BBCA Pharmaceutical Business Overview
- 6.19.3 Ma'AnShan BBCA Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Ma'AnShan BBCA Pharmaceutical Bromhexine Product Portfolio
- 6.19.5 Ma'AnShan BBCA Pharmaceutical Recent Developments
- 6.20 LGM Pharma
- 6.20.1 LGM Pharma Company Information
- 6.20.2 LGM Pharma Business Overview
- 6.20.3 LGM Pharma Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 LGM Pharma Bromhexine Product Portfolio
- 6.20.5 LGM Pharma Recent Developments
- 6.21 Boehringer Ingelheim
- 6.21.1 Boehringer Ingelheim Company Information
- 6.21.2 Boehringer Ingelheim Business Overview
- 6.21.3 Boehringer Ingelheim Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 6.21.4 Boehringer Ingelheim Bromhexine Product Portfolio
- 6.21.5 Boehringer Ingelheim Recent Developments
7 North America by Country
- 7.1 North America Bromhexine Sales by Country
- 7.1.1 North America Bromhexine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Bromhexine Sales by Country (2021-2026)
- 7.1.3 North America Bromhexine Sales Forecast by Country (2027-2032)
- 7.2 North America Bromhexine Market Size by Country
- 7.2.1 North America Bromhexine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Bromhexine Market Size by Country (2021-2026)
- 7.2.3 North America Bromhexine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Bromhexine Sales by Country
- 8.1.1 Europe Bromhexine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Bromhexine Sales by Country (2021-2026)
- 8.1.3 Europe Bromhexine Sales Forecast by Country (2027-2032)
- 8.2 Europe Bromhexine Market Size by Country
- 8.2.1 Europe Bromhexine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Bromhexine Market Size by Country (2021-2026)
- 8.2.3 Europe Bromhexine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Bromhexine Sales by Country
- 9.1.1 Asia-Pacific Bromhexine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Bromhexine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Bromhexine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Bromhexine Market Size by Country
- 9.2.1 Asia-Pacific Bromhexine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Bromhexine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Bromhexine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Bromhexine Sales by Country
- 10.1.1 South America Bromhexine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Bromhexine Sales by Country (2021-2026)
- 10.1.3 South America Bromhexine Sales Forecast by Country (2027-2032)
- 10.2 South America Bromhexine Market Size by Country
- 10.2.1 South America Bromhexine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Bromhexine Market Size by Country (2021-2026)
- 10.2.3 South America Bromhexine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Bromhexine Sales by Country
- 11.1.1 Middle East and Africa Bromhexine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Bromhexine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Bromhexine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Bromhexine Market Size by Country
- 11.2.1 Middle East and Africa Bromhexine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Bromhexine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Bromhexine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Bromhexine Value Chain Analysis
- 12.1.1 Bromhexine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Bromhexine Production Mode & Process
- 12.2 Bromhexine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Bromhexine Distributors
- 12.2.3 Bromhexine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst